Compounds > 5,8,11,14-eicosatetraynoic acid
Page last updated: 2024-10-21

5,8,11,14-eicosatetraynoic acid and Adenocarcinoma

5,8,11,14-eicosatetraynoic acid has been researched along with Adenocarcinoma in 2 studies

5,8,11,14-Eicosatetraynoic Acid: A 20-carbon unsaturated fatty acid containing 4 alkyne bonds. It inhibits the enzymatic conversion of arachidonic acid to prostaglandins E(2) and F(2a).

Adenocarcinoma: A malignant epithelial tumor with a glandular organization.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rao, GA1
Abraham, S1
Anderson, KM1
Wygodny, JB1
Ondrey, F1
Harris, J1

Other Studies

2 other studies available for 5,8,11,14-eicosatetraynoic acid and Adenocarcinoma

ArticleYear
Reduced growth rate of transplantable mammary adenocarcinoma in C3H mice fed eicosa-5,8,11,14-tetraynoic acid.
    Journal of the National Cancer Institute, 1977, Volume: 58, Issue:2

    Topics: 5,8,11,14-Eicosatetraynoic Acid; Adenocarcinoma; Animals; Arachidonic Acids; Aspirin; Dietary Fats;

1977
Human PC-3 prostate cell line DNA synthesis is suppressed by eicosatetraynoic acid, an in vitro inhibitor of arachidonic acid metabolism.
    The Prostate, 1988, Volume: 12, Issue:1

    Topics: 5,8,11,14-Eicosatetraynoic Acid; Adenocarcinoma; Arachidonic Acid; Arachidonic Acids; Calcimycin; Cy

1988